Xeligekimab (GR 1501) is a fully human monoclonal antibody that selectively neutralizes IL-17A, has potential anti-inflammatory activity, and can be used to study plaque psoriasis.
CAS Number:
[2382921-73-3]
Target:
IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted